These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11858981)

  • 1. Regulatory issues for clinical trials at EORTC: the way forward. European Organisation for Research and Treatment of Cancer.
    Baeyens AJ; Lacombe D
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S142-6. PubMed ID: 11858981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EORTC and drug development. European Organisation for Research and Treatment of Cancer.
    Lacombe D; Fumoleau P; Zwierzina H; Twelves C; Hakansson L; Jayson G; Lehmann F; Verweij J; ;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S19-23. PubMed ID: 11858959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing the challenge of intergroup studies in oncology: the EORTC experience. European Organisation for Research and Treatment of Cancer.
    Zurlo A; Therasse P
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S169-72. PubMed ID: 11858988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance in EORTC clinical trials. European Organisation for Research and Treatment of Cancer.
    Marinus A
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S159-61. PubMed ID: 11858986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EORTC Laboratory Research Division. European Organisation for Research and Treatment of Cancer.
    Brünner N; Double J; Fichtner I; Gescher A; Newell D; Oosterhuis W; Price P
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S14-8. PubMed ID: 11858958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Organisation for Research and Treatment of Cancer's point of view.
    Meunier F; Lacombe D
    Lancet; 2003 Aug; 362(9384):663. PubMed ID: 12944069
    [No Abstract]   [Full Text] [Related]  

  • 7. The EORTC Genito-Urinary Tract Cancer Group: 25 years of achievements and future strategies.
    Bono A; Zurlo A
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S71-4. PubMed ID: 11858969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EORTC Boron Neutron Capture Therapy (BNCT) Group: achievements and future projects.
    Sauerwein W; Zurlo A;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S31-4. PubMed ID: 11858961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scientific review of EORTC trials: the functioning of the New Treatment Committee and Protocol Review Committee.
    Lardot C; Steward W; Van Glabbeke M; Armand JP
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S24-30. PubMed ID: 11858960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achievements and goals of the EORTC Invasive Fungal Infections Group. European Organisation for Research and Treatment of Cancer.
    de Pauw BE; Herbrecht R; Meunier F;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S88-93. PubMed ID: 11858972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the EORTC pathologist in clinical trials: achievements and perspectives. European Organisation for Research and Treatment of Cancer.
    Spatz A; Ruiter DJ; Busch C; Theodorovic I; Oosterhuis JW
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S120-4. PubMed ID: 11858977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. It's time for chronotherapy!
    Coudert B; Focan C; Donato di Paola E; Lévi F;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S50-3. PubMed ID: 11858965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EORTC soft tissue and bone sarcoma group. European Organisation for Research and Treatment of Cancer.
    Donato Di Paola E; Nielsen OS;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S138-41. PubMed ID: 11858980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allan van Oosterom, President of the EORTC. European Organisation for the Research and Treatment of Cancer. Interview by Jeroen van der Boon.
    van Oosterom A
    Lancet Oncol; 2002 Jan; 3(1):58-61. PubMed ID: 11905607
    [No Abstract]   [Full Text] [Related]  

  • 15. 40 years of the EORTC: the evolution towards a unique network to develop new standards of cancer care. European Organisation for Research and Treatment of Cancer.
    Meunier F; van Oosterom AT
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S3-13. PubMed ID: 11858957
    [No Abstract]   [Full Text] [Related]  

  • 16. Moving the boundaries of international collaboration on clinical trials and QoL: experiences in oncology and legislation within the European Parliament.
    Bottomley A; Kirby T; Bean J; Walker J
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):43-5. PubMed ID: 23402444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European survey on ethical and legal framework of clinical trials in paediatrics: results and perspectives.
    Altavilla A; Giaquinto C; Ceci A
    J Int Bioethique; 2008 Sep; 19(3):17-48, 121-2. PubMed ID: 19244940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of infection in cancer patients. studies of the EORTC International Antimicrobial Therapy Group (IATG).
    Viscoli C;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S82-7. PubMed ID: 11858971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EORTC Brain Tumor Group: achievements and perspectives.
    Vecht ChJ; van den Bent MJ; Lacombe D
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S35-8. PubMed ID: 11858962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.